Home >
Law >
Intellectual Property / Patent / Copyright >
Antitrust in Pharmaceutical Markets and Geographical Rules of Origin

Antitrust in Pharmaceutical Markets and Geographical Rules of Origin

Author: Pierre Kobel; Pranvera Kellezi; Bruce Kilpatrick
Publisher: Springer-Verlag
ISBN: 9783319558127
Published In: September 2017
Format: Hardback
Jurisdiction: Switzerland ? Disclaimer:
Countri(es) stated herein are used as reference only

HKD 1,994.00

Download Order Form

Add to Wishlist
| Add to Compare

Description
Contents

Details

This book gathers international and national reports from across the globe on key questions in the field of antitrust and intellectual property.

The first part discusses the application of competition law in the pharmaceutical sector, which continues to be a focus for anti-trust authorities around the world. A detailed international report explores the extent to which the application of the competition rules in the pharmaceutical sector should be affected by the specific characteristics of those products and markets (including consumer protection rules, the need to promote innovation, the need to protect public budgets, and other public interest considerations). It provides an excellent comparative study of this complex subject, which lies at the interface between competition law and intellectual property law.

The second part of the book gathers contributions from various jurisdictions on the topic of "What rules should govern claims by suppliers about the national or geographic origin of their goods or services?" This section presents an international report, which offers an unparalleled comparative analysis of this topic, bringing together common themes and contrasting the various national provisions dealing with indications of origin, amongst other things.

The book also includes the resolutions passed by the General Assembly of the International League of Competition Law (LIDC) following a debate on each of these topics, which include proposed solutions and recommendations. The LIDC is a long-standing international association that focuses on the interface between competition law and intellectual property law, including unfair competition issues.

Part I: Antitrust in Pharmaceutical Markets: International Report by Stephen Dnes

Australia by Julie Clarke and Barbora Jedlickova

Austria by Gerhard Fussenegger and Rainer Schultes

Belgium by Koen T'Syen

Czech Republic by Kamil Nejezchleb

France by Liliana Eskenazi, Olivier Freget, Laetitia Ghebali, Clement Hubert, Martina Isola, Nizar Lajnef and Jean-Julien Lemonnier

Hungary by Gusztav Bacher and Andras Horvath

India by Arunabha Ganguli

Italy by Elisa Teti and Ottavia Raffaelli

Malta by Clement Mifsud-Bonnici

Poland by Aleksander Stawicki, Paulina Komorowska and Juliusz Krzyzanowski

Sweden by Vladimir Bastidas Venegas